Furthermore, delivery of another mRNA encoding bi-(ScFv)2 for EpCAM x CD3 (to target EpCAM on OV-90, an ovarian epithelial tumor cell line) also showed excellent activity and suggested that bispecific antibody-encoding mRNAs may be a robust means of treating cancer [207]. This evidence concerns the gene EPCAM and ovarian epithelial tumor.